Fundies.
English

Advanced Biomedical Technologies Inc.

EDGAR
ABMT Quarterly report (10-Q) · filed 2021-09-13

71 filing records in this dataset, filed from 2007-03-19 to 2021-09-13. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist

Latest quarter

Revenue

180 USD

2021 Q3 · USD

Exact inputs and evidence

Operating margin

-62,095.56%

2021 Q3 · %

Exact inputs and evidence

Operating cash flow

-81 thousand USD

2021 Q3 · USD

Exact inputs and evidence
  • Operating Cash Flow: -743038 USD Source
  • Operating Cash Flow: -662072 USD Source

Free cash flow

-82.9 thousand USD

2021 Q3 · USD

Exact inputs and evidence
  • Operating Cash Flow: -743038 USD Source
  • Operating Cash Flow: -662072 USD Source
  • Capital Expenditure: 51449 USD Source
  • Capital Expenditure: 49495 USD Source
Cash and cash equivalents
6.98 thousand USD Source
Exact value

6983 USD

Long-term debt including current maturities
Not available
Shares outstanding
70.2 million shares Source
Exact value

70224850 shares

Reported share-count change

0.36% · 250 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 69974850 shares · 2020-07-31· Source
  • 70224850 shares · 2021-07-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

110 thousand USD

2020-08-01 – 2021-07-31

Exact inputs and evidence
  • Revenue: 123587 USD · 2019-11-01 – 2020-10-31 Source
  • Revenue: 61251 USD · 2019-11-01 – 2020-07-31 Source
  • Revenue: 47233 USD · 2020-11-01 – 2021-01-31 Source
  • Revenue: 95 USD · 2021-02-01 – 2021-04-30 Source
  • Revenue: 180 USD · 2021-05-01 – 2021-07-31 Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2021-09-13.

Financial data available through: 2020-10-31.

Coverage by financial measure
  • Revenue: 2 of 11 periods available· newest 2020-10-31
  • Operating income: 6 of 11 periods available· newest 2020-10-31
  • Net income: 8 of 11 periods available· newest 2020-10-31
  • Operating cash flow: 8 of 11 periods available· newest 2020-10-31
  • Capital expenditure: 8 of 11 periods available· newest 2020-10-31
  • Total assets: 2 of 11 periods available· newest 2020-10-31
  • liabilities: No compatible figures in this window
  • Current assets: 2 of 11 periods available· newest 2020-10-31
  • Current liabilities: 2 of 11 periods available· newest 2020-10-31
  • Cash and cash equivalents: 2 of 11 periods available· newest 2020-10-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: 2 of 11 periods available· newest 2020-10-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    +960.2%

    Prior period

    USD 11,657

    –

    Current period

    USD 123,587

    –

    Exact inputs and evidence

    123587 − 11657 = 111930 USD

    11657 USD · 2018-11-01 – 2019-10-31

    Inspect prior input Prior source

    123587 USD · 2019-11-01 – 2020-10-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    +USD 276,820

    Prior period

    −USD 948,820

    –

    Current period

    −USD 672,000

    –

    Exact inputs and evidence

    -672000 − -948820 = 276820 USD

    -948820 USD · 2018-11-01 – 2019-10-31

    Inspect prior input Prior source

    -672000 USD · 2019-11-01 – 2020-10-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +USD 1.39 million

    Prior period

    −USD 742,530

    –

    Current period

    USD 646,660

    –

    Exact inputs and evidence

    646660 − -742530 = 1389190 USD

    -742530 USD · 2018-11-01 – 2019-10-31

    Inspect prior input Prior source

    646660 USD · 2019-11-01 – 2020-10-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    +65.4%

    Prior period

    USD 18,565

    –

    Current period

    USD 30,706

    –

    Exact inputs and evidence

    30706 − 18565 = 12141 USD

    18565 USD · 2018-11-01 – 2019-10-31

    Inspect prior input Prior source

    30706 USD · 2019-11-01 – 2020-10-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2020 2019-11-01 – 2020-10-31

  • Revenue USD 123,587 100% of revenue
  • Cost of revenue USD 51,817 42% of revenue
  • Operating expenses USD 518,394 419% of revenue
  • Operating income −USD 446,624 −361% of revenue
  • Tax, interest and other Derived USD 225,376 182% of revenue
  • Net income −USD 672,000 −544% of revenue

Cash

  • Operating cash flow USD 646,660 523% of revenue
  • Capital expenditure USD 30,706 25% of revenue
  • Free cash flow Derived USD 615,954 498% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2019 Operating loss: operating costs were 5,288% of revenue.
  • 2020 Operating loss: operating costs were 461% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2019 2018-11-01 – 2019-10-3111657 616395 Derived -604738 344082 Derived -948820 -761095 Derived
Source
2020 2019-11-01 – 2020-10-31123587 570211 Derived -446624 225376 Derived -672000 615954 Derived
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 123.6K 2020
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.133.5K100.1K66.7K33.4K0.020192020
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2019Revenue11657
2020Revenue123587

Revenue growth

Change in revenue from the same financial period one year earlier.

960.2% 2020
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.1,037%778%519%259%0%20192020
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2019Year over yearNo prior comparable period
2020Year over year960.2%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -361.4% 2020
Net margin -543.7% 2020
Free cash flow margin 498.4% 2020
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.1,189%-1,316%-3,821%-6,326%-8,831%20192020
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2019Operating margin-5,187.8%
2020Operating margin-361.4%
2019Net margin-8,139.5%
2020Net margin-543.7%
2019Free cash flow margin-6,529.1%
2020Free cash flow margin498.4%

Operating cash flow

Cash generated by the company’s normal business operations.

USD 646.7K 2020
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.757.8K354.9K-47.9K-450.8K-853.7K20192020
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2019Operating cash flow-742530
2020Operating cash flow646660

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 616K 2020
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.726.1K326.8K-72.6K-471.9K-871.3K20192020
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2019Free cash flow-761095
2020Free cash flow615954

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2019-10-31Liabilities / assetsNot reported
2020-10-31Liabilities / assetsNot reported

Current assets to current liabilities

Current assets divided by current liabilities.

0.04× 2020
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.0.05×0.03×0.02×0.01×0.00×20192020
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2019Current assets / current liabilities0.02×
2020Current assets / current liabilities0.04×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2010 2009-11-01 – 2010-10-31
−USD 816,799
Exact value

Exact value: -816799 USD

2009-11-01 – 2010-10-31: -816799 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 408,410
Exact value

Exact value: -408410 USD

2009-11-01 – 2010-10-31: -408410 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 5,638
Exact value

Exact value: 5638 USD

2009-11-01 – 2010-10-31: 5638 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 414,048
Calculation and evidence

-408410 − 5638 USD

Exact free cash flow: -414048 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2011 2010-11-01 – 2011-10-31
−USD 487,439
Exact value

Exact value: -487439 USD

2010-11-01 – 2011-10-31: -487439 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 212,027
Exact value

Exact value: -212027 USD

2010-11-01 – 2011-10-31: -212027 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 47,843
Exact value

Exact value: 47843 USD

2010-11-01 – 2011-10-31: 47843 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 259,870
Calculation and evidence

-212027 − 47843 USD

Exact free cash flow: -259870 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2012 2011-11-01 – 2012-10-31
−USD 758,525
Exact value

Exact value: -758525 USD

2011-11-01 – 2012-10-31: -758525 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 609,835
Exact value

Exact value: -609835 USD

2011-11-01 – 2012-10-31: -609835 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 59,410
Exact value

Exact value: 59410 USD

2011-11-01 – 2012-10-31: 59410 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 669,245
Calculation and evidence

-609835 − 59410 USD

Exact free cash flow: -669245 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2016 2015-11-01 – 2016-10-31
−USD 724,737
Exact value

Exact value: -724737 USD

2015-11-01 – 2016-10-31: -724737 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 371,653
Exact value

Exact value: -371653 USD

2015-11-01 – 2016-10-31: -371653 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1,699
Exact value

Exact value: 1699 USD

2015-11-01 – 2016-10-31: 1699 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 373,352
Calculation and evidence

-371653 − 1699 USD

Exact free cash flow: -373352 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2017 2016-11-01 – 2017-10-31
−USD 691,600
Exact value

Exact value: -691600 USD

2016-11-01 – 2017-10-31: -691600 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 557,712
Exact value

Exact value: -557712 USD

2016-11-01 – 2017-10-31: -557712 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 453
Exact value

Exact value: 453 USD

2016-11-01 – 2017-10-31: 453 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 558,165
Calculation and evidence

-557712 − 453 USD

Exact free cash flow: -558165 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2018 2017-11-01 – 2018-10-31
−USD 953,320
Exact value

Exact value: -953320 USD

2017-11-01 – 2018-10-31: -953320 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 832,421
Exact value

Exact value: -832421 USD

2017-11-01 – 2018-10-31: -832421 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 64,405
Exact value

Exact value: 64405 USD

2017-11-01 – 2018-10-31: 64405 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 896,826
Calculation and evidence

-832421 − 64405 USD

Exact free cash flow: -896826 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2019 2018-11-01 – 2019-10-31
−USD 948,820
Exact value

Exact value: -948820 USD

2018-11-01 – 2019-10-31: -948820 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 742,530
Exact value

Exact value: -742530 USD

2018-11-01 – 2019-10-31: -742530 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 18,565
Exact value

Exact value: 18565 USD

2018-11-01 – 2019-10-31: 18565 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 761,095
Calculation and evidence

-742530 − 18565 USD

Exact free cash flow: -761095 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2020 2019-11-01 – 2020-10-31
−USD 672,000
Exact value

Exact value: -672000 USD

2019-11-01 – 2020-10-31: -672000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 646,660
Exact value

Exact value: 646660 USD

2019-11-01 – 2020-10-31: 646660 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 30,706
Exact value

Exact value: 30706 USD

2019-11-01 – 2020-10-31: 30706 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 615,954
Calculation and evidence

646660 − 30706 USD

Exact free cash flow: 615954 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

71 filings · 2,285 latest values · 2,285 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001385799, 1385799, ABMT, edgar:1385799

Also known as Advanced BioMedical Technologies, Inc., Advanced Biomedical Technologies Inc., Geostar Mineral CORP